“Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients”, Clinics, vol. 72, no. 5, pp. 317–324, May 2017, doi: 10.6061/clinics/2017(05)10.